Simultaneously, in the context of lung cancer, CXCL13 was considered to be a carcinogenic cytokine with significantly enhanced expression levels and facilitating cancer cell invasion through the epithelial-mesenchymal transition (EMT) process (Kazanietz et al., 2019). This evidence concerns the gene CXCL13 and cancer.